October 15, 2021

Sinopharm Covid 19 Vaccine is Now Available in Malaysia

KUALA LUMPUR, 15 October 2021 – Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) is further strengthening COVID-19 vaccination efforts in Malaysia with the distribution of the Sinopharm COVID-19 vaccine. Earlier, Duopharma Biotech had entered into an agreement to import the vaccine from Beijing, China, covering a collaboration for the Malaysian market. Duopharma (M) Sdn. Bhd., a wholly owned subsidiary of Duopharma Biotech has been authorised by Sinopharm as the product registration holder and to engage in the sales and distribution of the vaccine.